Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9867821
SERIAL NO

13783772

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to therapeutic agents which are atypical antipsychotics and which are useful in the treatment of neurological and psychiatric disorders associated with dopamine D2 and serotonin 5-HT2A neurotransmission dysfunction.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SHARP & DOHME CORP126 E LINCOLN AVENUE RAHWAY NJ 07065
SUMITOMO DAINIPPON PHARMA CO LTD6-8 DOSHOMACHI 2-CHOME CHUO-KU OSAKA-SHI OSAKA 5418524 ?5418524

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bilodeau, Mark T Lansdale, US 103 1074
Nanda, Kausik K Norristown, US 16 68
Trotter, B Wesley Glenside, US 35 143

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 16, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 16, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00